Issues related to drug supply chain and drug shortages. Issues related to bioidentical compounded hormones.
2025 · 1st Quarter (Jan 1 - Mar 31)
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA
Filed by THORN RUN PARTNERS.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Termination
- Posted
- Apr 17, 2025
- Income
- $30,000.00
- Expenses
- Not reported
- Registrant
- THORN RUN PARTNERS
- Filing UUID
- 5fc241fd-6067-40d0-96ba-eb596c1bed24
- Termination date
- Feb 28, 2025
Literal source text
Lobbying issues and bill citations
Issues related to the Drug Quality and Security Act, Compounding Pharmacy, Reimbursement, and Patient Access, animal compounding, and H.R.167 - Patient Access to Urgent-Use Pharmacy Compounding Act of 2023. H.R.3810 - Drug Origin Transparency Act of 2023.
Medicare Part D reimbursement of bulk substances.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.